Literature DB >> 8095921

Receptor subtype involved and mechanism of norepinephrine-induced stimulation of glutamate uptake into primary cultures of rat brain astrocytes.

T Fahrig1.   

Abstract

Glutamate uptake into rat brain astrocytes is potently stimulated by addition of norepinephrine (NE). This effect is mediated by alpha 1-adrenergic receptors expressed by these cells (Hansson and Rönnbäck: Life Sci 44:27, 1989; Brain Res 548:215, 1991). The present study was undertaken in order to identify the adrenergic receptor subtype involved, and to determine the sequence of events following receptor activation. NE increased glutamate uptake rates in a dose- and time-dependent manner (EC50 = 6 microM). Both, the selective alpha 1-receptor antagonist prazosin (IC50 = 2.5 microM) and the alpha 1b-adrenergic receptor subtype specific alkylating agent chloroethyl-clonidine (CEC, 100 microM) prevented NE (100 microM) evoked stimulation of glutamate uptake. Furthermore, omission of Ca2+ from the extracellular medium had no significant influence on NE-induced increase in glutamate uptake, indicating that the stimulatory effect is mediated by alpha 1b-adrenergic receptors. Treatment of cells with pertussis toxin (PTX) for 24 h or with 12-O-tetradecanoylphorbol-13-acetate (TPA) for 30-45 min prior to NE addition abolished the NE-mediated effect on glutamate uptake. Addition of TPA alone resulted in a rapid increase of glutamate uptake, which declined to control levels when TPA was applied 30 min prior to uptake initiation by glutamate. The increase in glutamate uptake elicited by TPA and NE added at the same time showed no additivity of the stimulatory effect resulting from treatment with each agent alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095921     DOI: 10.1002/glia.440070304

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.

Authors:  Maria I Wenner; Garth L Maker; Linda F Dawson; Peter D Drummond; Ian Mullaney
Journal:  Cytotechnology       Date:  2015-09-25       Impact factor: 2.058

Review 2.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

3.  Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i.

Authors:  Leif Hertz; Ditte Lovatt; Steven A Goldman; Maiken Nedergaard
Journal:  Neurochem Int       Date:  2010-04-07       Impact factor: 3.921

4.  Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes.

Authors:  Masaru Yoshizumi; James C Eisenach; Ken-ichiro Hayashida
Journal:  Eur J Pharmacol       Date:  2011-12-21       Impact factor: 4.432

5.  Subcellular calcium oscillators and calcium influx support agonist-induced calcium waves in cultured astrocytes.

Authors:  S Yagodin; L A Holtzclaw; J T Russell
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

6.  Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

Authors:  Michelle J Chandley; Katalin Szebeni; Attila Szebeni; Jessica Crawford; Craig A Stockmeier; Gustavo Turecki; Jose Javier Miguel-Hidalgo; Gregory A Ordway
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

7.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

8.  IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism.

Authors:  Daniel Chesik; Nadine Wilczak; Jacques De Keyser
Journal:  Int J Med Sci       Date:  2008-08-06       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.